Ildiko Madurka
2PUBLICATIONS
3CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Sep 14, 2022
DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function.Ildiko Madurka, Alexander Vishnevsky, Joan B Soriano
Pageof 1

